LAUSANNE, Switzerland, Dec. 7, 2023 (Globe Newswire) — Distalmotion, a pioneer in new on-demand robotics, has hired medical device industry leader Greg Roche as CEO. If approved by shareholders, Roche will also join the company's board of directors. In his role, Mr. Roche will lead Distalmotion's Dexter US and EU expansion efforts.® Surgical Robotics provides experienced insight and guidance for the next stage of your company's growth strategy.
Roche joins Distalmotion with more than 20 years of commercial and operational experience in the medtech industry, bringing a wealth of expertise across laparoscopic surgery, endoscopic visualization, and surgical robotics.
Most recently, Roche served as CEO of Avaterra Medical, where he furthered his leadership and experience in soft tissue robotics. Previously, he served as Global President of Robotics and Technology for Zimmer Biomet, where he led the successful global launch of ROSA.® The company achieved above-market growth in part because it developed the Robotic Knee System and developed an innovative business model tailored to meet the unique demands of ambulatory surgical centers (ASCs). Starting in the early 2000s, Roche held multiple U.S. commercial and leadership roles across Stryker. Roche is in a distinct position to bring a wealth of commercial and marketing experience from each of these roles to his Distalmotion.
“I'm excited to join Distalmotion. We have an incredibly talented team that is positioning Distalmotion as a leader in the next generation of surgical robotics,” said Michael Friedrich, former CEO of Distalmotion. I would like to thank him for continuing in his new role as COO, laying the foundation that truly sets us on the path to future success,” commented Roche. “Dexter is a great product that will enable broader access to robotic surgery. We look forward to building on the evidence.”
“We are very proud to welcome Greg to the Distalmotion leadership team,” said Rick Anderson, Chairman of the Board. “Greg's global experience in this space, track record of US launches, and deep understanding of our market segments are a great fit and position the company for a very exciting future. ”
About Distalmotion
Distalmotion is a medical device company founded in Lausanne, Switzerland, with a mission to establish a new standard of care through robotic innovation. Our goal is to bring the benefits of robotic surgery to more hospitals, more surgeons, and more patients around the world. To do so, the company developed the surgical robot Dexter.®. Dexter removes robotic barriers and empowers surgeons with superior technology, ultimately improving patient access to best-in-class minimally invasive surgery.
For more information, please visit www.distalmotion.com. Also, follow @Distalmotion on LinkedIn/Twitter.
###
-
Industry leader Greg Roche joins Distalmotion as CEO
